AU2003304576A1 - Cis-hydrogenated fatty acid coating of medical devices - Google Patents

Cis-hydrogenated fatty acid coating of medical devices

Info

Publication number
AU2003304576A1
AU2003304576A1 AU2003304576A AU2003304576A AU2003304576A1 AU 2003304576 A1 AU2003304576 A1 AU 2003304576A1 AU 2003304576 A AU2003304576 A AU 2003304576A AU 2003304576 A AU2003304576 A AU 2003304576A AU 2003304576 A1 AU2003304576 A1 AU 2003304576A1
Authority
AU
Australia
Prior art keywords
cis
fatty acid
medical devices
acid coating
hydrogenated fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003304576A
Other languages
English (en)
Inventor
Ivan De Scheerder
Pierre Jacobs
Johan Martens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KU Leuven Research and Development
Original Assignee
KU Leuven Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KU Leuven Research and Development filed Critical KU Leuven Research and Development
Publication of AU2003304576A1 publication Critical patent/AU2003304576A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
AU2003304576A 2003-11-11 2003-11-17 Cis-hydrogenated fatty acid coating of medical devices Abandoned AU2003304576A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0326180.7A GB0326180D0 (en) 2003-11-11 2003-11-11 Biocompatible coating of medical devices
GB0326180.7 2003-11-11
PCT/BE2003/000201 WO2005053767A1 (fr) 2003-11-11 2003-11-17 Revetement d'acide gras cis-hydrogene de dispositifs medicaux

Publications (1)

Publication Number Publication Date
AU2003304576A1 true AU2003304576A1 (en) 2005-06-24

Family

ID=29726258

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003304576A Abandoned AU2003304576A1 (en) 2003-11-11 2003-11-17 Cis-hydrogenated fatty acid coating of medical devices

Country Status (3)

Country Link
AU (1) AU2003304576A1 (fr)
GB (1) GB0326180D0 (fr)
WO (1) WO2005053767A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466432A1 (fr) 2001-11-08 2003-05-15 Atrium Medical Corporation Dispositif intraluminal avec revetement contenant une substance therapeutique
WO2006036982A2 (fr) 2004-09-28 2006-04-06 Atrium Medical Corporation Revetement d'administration de medicament pouvant etre utilise avec une endoprothese vasculaire
WO2006036969A2 (fr) 2004-09-28 2006-04-06 Atrium Medical Corporation Formation d'une couche barriere
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
CA2626030A1 (fr) 2005-10-15 2007-04-26 Atrium Medical Corporation Gels hydrophobes reticules pour revetements bioabsorbables de vecteur de medicament
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US8486478B2 (en) 2007-11-08 2013-07-16 International Great Brands LLC Structured lipid compositions
US8206772B2 (en) 2007-11-08 2012-06-26 Kraft Foods Global Brands Llc Structured lipid compositions and methods of formulation thereof
DE102008020415A1 (de) 2008-04-24 2009-10-29 Biotronik Vi Patent Ag Biodegradierbare metallische Stents mit Wachsschicht
WO2010008815A1 (fr) 2008-06-24 2010-01-21 Bioactive Surgical, Inc. Sutures chirurgicales incoporées dans des cellules souches ou autres matériaux bioactifs
CA2769878A1 (fr) 2008-08-07 2010-02-11 Bioactive Surgical, Inc. Revetements de capture et d'immobilisation de cellules souches pour dispositifs et implants medicaux
WO2010033909A2 (fr) 2008-09-22 2010-03-25 Boston Scientific Neuromodulation Corporation Dispositifs médicaux implantables ou insérables
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
CA2466432A1 (fr) * 2001-11-08 2003-05-15 Atrium Medical Corporation Dispositif intraluminal avec revetement contenant une substance therapeutique

Also Published As

Publication number Publication date
GB0326180D0 (en) 2003-12-17
WO2005053767A1 (fr) 2005-06-16

Similar Documents

Publication Publication Date Title
AU2003304576A1 (en) Cis-hydrogenated fatty acid coating of medical devices
AU2003293347A1 (en) Antimicrobial fatty acid containing suture coating
AU2003291805A1 (en) Lubricious coating for medical devices
AU2003236991A1 (en) Representations of processes
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
GB2419832B (en) Coating of surgical devices
AU2003281534A1 (en) Preparation of acrylic polymer sol for coating
AUPS082102A0 (en) Therapeutic properties of oils
AU2003238605A1 (en) Dynamic representations of processes
AU2003228487A1 (en) Fatty acid containing teat dip
HK1072568A1 (en) Use of new etonogestrel esters
WO2005033343A8 (fr) Nouveaux variants d'epissage du gene dkkl1 humain
AU2003902413A0 (en) Modification of fatty acid biosynthesis
AU2003268923A1 (en) Treatment of aml
AU2003217900A1 (en) Preparation of unsaturated polyesters
AU2003272198A1 (en) Storage of blood
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003297849A1 (en) Anti-inflammatory coating for implantable medical devices
SG107315A1 (en) Use of conjugated linoleic acid derivatives
AU2003266271A1 (en) Regulation of human esterase
AU2003274359A1 (en) Treatment of fluids
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003240450A1 (en) Manufacture of ketopantolactone
AU2001249403A1 (en) Treatment of rosacea using lipoic acid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase